Trogenix

Raised $93.8M in a Series A round, announced 7 October 2025.

Latest round Series ACountry United KingdomSector Health

Round

Funds patient testing and acceleration of clinical trials.

Amount: $93.8M
Stage: Series A
Announced: 7 October 2025
Lead: IQ Capital
Other investors: 4BIO Capital, Cancer Research Horizons, Brain Tumor Investment Fund, Eli Lilly, Meltwind, LongeVC, Calculus Capital
Use of funds: Funds patient testing and acceleration of clinical trials.
Checked: Amount and date matched across 2 press sources
Sources: Trogenix raises €80M Series A (amount in EUR as listed by tech.eu) webrazzi.com
Trogenix raises €80M Series A (amount in EUR as listed by tech.eu) funding.tech.eu

Gene therapy and immunotherapy platform for hard-to-treat cancers

How much has Trogenix raised?

Trogenix raised $93.8M in a Series A round, announced on 7 October 2025.

Who invested in Trogenix?

IQ Capital led. Investors include IQ Capital, 4BIO Capital, Cancer Research Horizons, Brain Tumor Investment Fund, Eli Lilly and Meltwind.